Here's What Investors Need to Know About Pfizer and BioNTech's Vaccine Launch

In this video from Motley Fool Live recorded on Dec. 14, Corinne Cardina, bureau chief of healthcare and cannabis, and Fool.com contributor Brian Orelli discuss the launch of the first coronavirus vaccine from Pfizer (NYSE: PFE) and BioNTech (NASDAQ: BNTX). While the Food and Drug Administration authorized the vaccine, there were some unanswered questions from the advisory committee meeting. They also discuss how difficult it is for investors to estimate the manufacturing side of the rollout.

Continue reading

Source Fool.com